Jianxun Ding
Papers
1
Total Citations
2
H-Index
1
About
Jianxun Ding is a leading researcher in nanomedicine and drug delivery, with a primary focus on developing advanced nanotheranostic platforms for combating viral hepatitis and hepatocellular carcinoma. His major contributions lie in the innovative application of CRISPR/Cas systems within nanoscale frameworks, where he has pioneered the concept of "smart enzymatic robots" that can precisely target and treat liver diseases. This work, highlighted in his highly cited 2021 Advanced Science paper, demonstrates how nanoscale CRISPR/Cas technologies can be engineered for both diagnostic and therapeutic purposes, offering a dual-function approach to tackling some of the most challenging liver pathologies. With over 2 citations on this seminal work alone, Ding's research has significantly advanced the field of nanotheranostics, bridging the gap between gene editing and nanomedicine. His collaborative efforts with colleagues Yeh‐Hsing Lao, Qi Zhang, Yu Tao, and Mingqiang Li have established a new paradigm for treating viral hepatitis and hepatocellular carcinoma, positioning him as a key innovator in the development of next-generation, precision-guided therapeutic systems for liver diseases.
Research Focus
Key Achievements
Top Papers
- 1